Drawing for BLU-V

USPTO serial 79139362

BLU-V

Reviewed by CopyMark Law Group

Reg. 4622998Status 404
Filing date
Status date
Registration date
Oct 21, 2014
Examiner
DE JONGE, KATHLEEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BLU-V?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lorraine Linford

Lorraine Linford Cozen O'Connor999 3rd Avenue#1900Seattle, WA 98104

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for industrial and scientific purposes; biochemical and biotechnological products for industrial and scientific purposes, namely, reagents and solvents for sample preparation, the modification and manipulation of cells, the labeling, separating, identifying, quantifying, isolating, purifying, amplifying or analyzing of biopolymers, in the nature of nucleic acids, proteins, macromolecules and biologically active substances, and for detection of contaminating biomolecules; kits for laboratory or research use comprising chemicals for sample preparation, the modification and manipulation of cells, the labeling, separation, identification, quantification, isolation, purification, amplification and analysis of biopolymers, and for detection of contaminating biomolecules, in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample materialSECTION 71 - CANCELLED—
005Diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical and veterinary use, in particular for sample preparation, the modification and manipulation of cells, the labeling, separation, identification, quantification, isolation, purification, amplification and analysis of biopolymers, in the nature of nucleic acids, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products, namely, reagents and solvents for medical and veterinary use for sample preparation, the modification and manipulation of cells, the labeling, separating, identifying, quantifying, isolating, purifying, amplifying or analyzing of biopolymers, and for detection of contaminating biomolecules, in the nature of nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits containing preparations for human medical and veterinary diagnostic purposes, in particular for sample preparation, the modification and manipulation of cells, the labeling, separation, identification, quantification, isolation, purification, amplification and analysis of biopolymers, and for detection of contaminating biomolecules in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample materialSECTION 71 - CANCELLED—
009Scientific apparatus, instruments and equipment, namely, test tubes, laboratory vessels, columns for laboratory use, laboratory sample holders, laboratory boxes for incubation of biological or biochemical samples, and devices for light exposure of biological or biochemical samples for research and analysis purposes, and laboratory apparatus, measuring apparatus and instruments for use with products for human medical and veterinary medical diagnostic purposes, for sample preparation, modification and manipulation of cells, labeling, separation, identification, quantification, isolation, purification, amplification or analysis of biopolymers, and for detection of contaminating biomolecules, in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample materialSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 3, 2024DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Mar 3, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 11, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
May 5, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 5, 2022INPCINVALIDATION PROCESSED—
Jan 7, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 7, 2021C71TCANCELLED SECTION 71—
Oct 21, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 7, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 3, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 19, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 19, 2015FIMPFINAL DISPOSITION PROCESSED—
Jan 21, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 21, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 5, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 5, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 1, 2014GPNXNOTIFICATION PROCESSED BY IB—
Jul 16, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 16, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 16, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 30, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 24, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 24, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 24, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 18, 2014ALIEASSIGNED TO LIE—
Jun 10, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 17, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 31, 2013RFNTREFUSAL PROCESSED BY IB—
Dec 13, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 12, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 12, 2013RFRRREFUSAL PROCESSED BY MPU—
Dec 11, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 10, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2013DOCKASSIGNED TO EXAMINER—
Dec 9, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 6, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance